MET and breast cancer: For example, in some breast cancers and in human squamous cell carcinomas, Matriptase is responsible for cancer progression by increasing cell proliferation and invasiveness via an HGF (Hepatocyte growth factor)—cMET—pAKT pathway [50,71].